FAST NEWS: InnoCare Pharma Losses Double on Higher Costs And Exchange Deficit
The latest: InnoCare Pharma Ltd. (9969.HK) issued a profit warning Friday, estimating a net loss of no more than 495 million yuan ($73 million) for the first half of this year,…
RELATED ARTICLES
-
FAST NEWS: InnoCare inches closer to profitability on strong sales gains
9969.HK
-
FAST NEWS: InnoCare’s loss narrows on higher lymphoma drug sales
9969.HK
-
Debt pressures cast cloud over Fosun Pharma results
2196.HK 600196.SHG
-
Fosun Pharma, CanSino take different paths as Covid lift fade
2196.HK 6185.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
Kintor shares plunge after hair-loss drug flops in clinical trials
9939.HK
-
AstraZeneca pays hefty price for Chinese weight-loss drug
AZN.US
Discover hidden China stock gems in our weekly newsletter